Research programme: Pim kinase inhibitors - Array BioPharma

Drug Profile

Research programme: Pim kinase inhibitors - Array BioPharma

Alternative Names: AR 29; ARRY-Pim-i

Latest Information Update: 12 Aug 2011

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Array BioPharma
  • Class Small molecules
  • Mechanism of Action Protein-serine-threonine kinase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • No development reported Myeloid leukaemia

Most Recent Events

  • 12 Aug 2011 No development reported - Preclinical for Myeloid leukaemia in USA (PO)
  • 08 Dec 2009 Pharmacodynamics data from preclinical trials in Myeloid leukaemia presented at the 51st Annual Meeting and Exposition of the American Society of Hematology (ASH-2009)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top